Acupuncture for the Immune System in Radiation Cancer Patients
Does Radiation Therapy Adversely Affect the Immune System, and Can Acupuncture Ameliorate the Effect? A Pilot Study
Purpose/Goal: To investigate how long course radiation therapy (RT), both with or without chemotherapy, affects the immune system, and to determine if acupuncture can modify these effects in patients undergoing curative radiation therapy for gastrointestinal (GI) or genitourinary (GU) cancers.
Clinical or Research Questions:
- Does RT reduce immune biomarkers in treated subjects?
- Which biomarkers are most affected by treatment?
- Is acupuncture a feasible option to help ameliorate any biomarker effects?
- Does RT affect subject symptoms?
- Is acupuncture a feasible option to help ameliorate any symptom effects?
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Research indicates that patients undergoing curative RT for various cancers experience adverse immune effects, as indicated by reduced biomarker levels and activity. RT has been observed to cause a striking reduction in total lymphocyte count, affecting mainly the T-cells. Furthermore, the reduction in the lymphocyte count after RT has been correlated with poorer outcome for bladder cancer, head and neck cancer, uterine cancer, and brain metastases.
Research into the use of complementary and alternative medicine (CAM) has been conducted to determine the utility of these treatments in addressing the unmet needs of many patients with cancer. There is preliminary evidence that acupuncture, in particular, is successful at improving many cancer and treatment associated effects. Earlier studies have indicated that acupuncture can play a role in regulating immune system response to various morbidities, including chemotherapy induced immunosuppression. However, little research has examined is potential for radiation therapy patients
This pilot study aims to assess a wide range of general immune biomarkers to identify biomarkers most affected by RT. Through use of a symptom assessment survey, changes in self reported symptoms will also be recorded. The feasibility of acupuncture as a strategy to ameliorate any adverse immune or symptom effects will also be examined. This information could be very useful in planning future studies on RT and the immune system, or the potential immune benefits of acupuncture.
Tipo de estudo
Estágio
- Fase 3
Contactos e Locais
Locais de estudo
-
-
British Columbia
-
Victoria, British Columbia, Canadá, V8R 6V5
- BC Cancer Agency - Vancouver Island Centre
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- patients who will receive ≥ 4 weeks of curative intent long course RT for a GI or GU malignancy
- patients may or may not have received / be receiving adjuvant chemotherapy
- anticipated survival of at least 12 months
- able to visit the BCCA VIC for treatment and 2 follow up visits
Exclusion Criteria:
- scheduled to receive RT for a period of less than 4 weeks
- expected survival period is less than 12 months
- are on anticoagulants
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Não randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Sem intervenção: Standard treatment
Patients receiving standard radiation therapy for gastrointestinal or urogenital cancers. All subjects will be asked to give 20 mL of blood and complete the Edmonton Symptom Assessment Form (ESAS) on 3 occasions:
|
|
|
Experimental: Acupuncture
Patients receiving standard radiation therapy for gastrointestinal or urogenital cancers with concurrent acupuncture once a week for 4 weeks. All subjects will be asked to give 20 mL of blood and complete the Edmonton Symptom Assessment Form (ESAS) on 3 occasions:
|
Subjects will be asked to report symptom concerns. Subjects are requested to wear loose clothing as most acupoints lie at or distal to the elbow and knee. Sterile single use steel needles (ITO Adiquip 0.25 x 4.0 cm) will be inserted to a depth of 1 - 2 cm at acupoints thought to impact positively on the immune system. An ITO ES-160 Electrostimulator will be used to mimic the "pecking" technique of manual stimulation. Following needle insertion by the acupuncturist, a nurse or acupuncture student may assist by attaching electrodes to provide electrical stimulation. A 0.3 ms duration, 4 HZ, alternating current will be delivered with voltage set just below the pain threshold of the patient. After 20 minutes, the needles will be removed. Acupoints will include:
Additional points may be added based on the symptom concerns reported. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in immune biomarker levels
Prazo: As measured using 3 blood samples collected: before radiation; at 1st follow up 4-10 weeks after radiation completion; at second follow up 6 months after 1st follow up
|
Change in 21 immune cell types after RT (levels before RT - levels 1st follow up) will be analyzed for controls (to determine if RT reduces immune markers) and experimentals (to determine if acupuncture ameliorates RT effects).
Results will be analyzed to determine which biomarkers experienced the largest changes for controls (to identify biomarkers affected by RT) and experimentals (to determine which biomarkers are particularly improved by acupuncture).
Change in cell levels during follow up (levels 1st follow up - levels 2nd follow up), will be analyzed to determine duration of changes.
|
As measured using 3 blood samples collected: before radiation; at 1st follow up 4-10 weeks after radiation completion; at second follow up 6 months after 1st follow up
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Changes in Symptom Scores
Prazo: As measured using the Edmonton Symptom Assessment Scores (ESAS) completed: before radiation; at 1st follow up 4-10 weeks after radiation completion; at second follow up 6 months after 1st follow up
|
The change in ESAS following treatment (ESAS before treatment - ESAS at first follow up) will be analyzed for control subjects (to determine if RT affects subject symptoms) and experimental subjects (to determine if acupuncture ameliorates any symptom effects).
For each subject, results will be analyzed for the change in the total ESAS after treatment, as well as the largest change in ESAS for any single symptom.
Also, change in ESAS in the follow up period (ESAS at first follow up - ESAS at second follow up), will be analyzed in order to determine the duration of any changes.
|
As measured using the Edmonton Symptom Assessment Scores (ESAS) completed: before radiation; at 1st follow up 4-10 weeks after radiation completion; at second follow up 6 months after 1st follow up
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Jan T W Lim, MD, BC Cancer Agency and University of British Columbia
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Estimativa)
Atualizações de registro de estudo
Última Atualização Postada (Estimativa)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- BCCA- H10-02105
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Neoplasias urogenitais
-
University Hospital, LilleMinistry of Health, FranceRecrutamento
-
Clinique Beau SoleilConcluído
-
Alexandria UniversityConcluídoProlapso UrogenitalEgito
-
Queen Mary University of LondonHoffmann-La RocheRecrutamentoCâncer UrogenitalReino Unido
-
Rennes University HospitalRecrutamento
-
Peking Union Medical College HospitalDesconhecido
-
Medical University of GrazRecrutamento
-
Assiut UniversityAinda não está recrutandoMetástases ósseas | Câncer Urogenital
-
Ankara UniversityAinda não está recrutandoSintomas do Trato Urinário Inferior | Incontinencia urinaria | Urodinâmica | Doença Urogenital FemininaPeru
-
Zealand University HospitalRecrutamento
Ensaios clínicos em Medical Acupuncture
-
Soterix MedicalGeorgetown University; National Institute of Neurological Disorders and Stroke... e outros colaboradoresConcluído
-
Soterix MedicalNYU Langone HealthConcluídoDepressão resistente ao tratamento | Depressão UnipolarEstados Unidos
-
Abbott Medical DevicesConcluído
-
Abbott Medical DevicesRescindido
-
Baylor College of MedicineAtivo, não recrutandoDefeitos do tubo neuralEstados Unidos
-
Cordio MedicalConcluído
-
Baylor College of MedicineMaterna MedicalConcluídoLágrima, Órgão Pélvico, Trauma ObstétricoEstados Unidos
-
Idiag AGConcluídoSíndrome da Apneia Obstrutiva do SonoAlemanha
-
Columbia UniversityRecrutamentoEstenose da Artéria Coronária Descendente Anterior EsquerdaEstados Unidos
-
Hospital San PaoloDesconhecidoPancreatite pós-CPREItália